Listening to Mom 2: Neural, Clinical and Language Outcomes
Premature Birth
About this trial
This is an interventional treatment trial for Premature Birth focused on measuring Premature Birth, Obstetric Labor, Premature, Obstetric Labor Complications, Pregnancy Complications
Eligibility Criteria
Inclusion Criteria:
- Infants born preterm at Stanford Children's Hospital between 24 0/7 - 31 6/7 weeks gestational age
Exclusion Criteria:
- Congenital anomalies
- Recognizable malformation syndromes
- Active seizure disorders
- History of Central Nervous System infections
- Hydrocephalus
- Major sensori-neural hearing loss
- Likelihood to be transferred from NICU to alternate care facility or home environment prior to 36 weeks PMA and/or brain MRI scan
- Intraventricular Hemorrhage Grades III-IV
- Cystic periventricular leukomalacia (PVL)
- Surgical treatment for necrotizing enterocolitis
- Small for gestational age (SGA) <3 percentile and/or Intra-uterine growth restriction (IUGR) no head sparing
- Twin-to-twin transfusions
Sites / Locations
- Stanford University - Lucile Packard Children's HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Language Treatment Arm
Control Treatment Arm
An infant participant randomized to the language treatment arm will be played recordings of his/her mother's voice 2-3 hours daily in the intermediate care nursery until discharge.
An infant participant randomized to the control treatment arm will receive standard of care. Standard of care does not include being played recordings of his/her mother's voice while admitted to the intermediate care nursery. However, an infant randomized to the control treatment will have the same auditory equipment placed in his/her isolette or crib as an infant randomized to the Language Treatment Arm.